ArticleThe Journal of clinical investigation2026

Targeting RANKL-independent osteoclastogenesis overcomes denosumab resistance in models of ER+ breast cancer bone metastasis.

Qun Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.